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Background
Mutations in the APC gene lead to Familial adenoma-
tous polyposis (FAP) and an attenuated form of this
condition (AFAP). Based on previous work with muta-
tion-verified patients from a large AFAP kindred, we
showed that AFAP patients may be under-diagnosed,
in the absence of a genetic diagnosis. For example, for
patients between 30 and 79 years of age, 28% had
fewer than 10 adenomas; 22% had fewer than 6 adeno-
mas, and 7% had no polyps. Therefore, depending on
the number of adenomas considered more consistent
with sporadic, rather than a familial predisposition,
and the availability or lack of known family history, up
to ~25% of mutation-carrying AFAP patients may be
missed in clinical practice. We sought to address this
challenge by profiling mutation-independent adenoma
formation among the mutation-negative carriers in this
kindred.
Methods
Careful endoscopic evaluation of the AFAP cases has
been previously reported, and these data were used for
the mutation-positive individuals. The Utah Population
Database (UPDB) includes Utah genealogies linked with
medical records serving 85% of the Utah population.
The database was queried for all descendents of known
mutation-negative brancheso ft h i sl a r g ek i n d r e dw h o
had undergone colonoscopy procedures between 1995
and 2009. The queries collected data on age, gender,
polyp type, pathology and cancer diagnoses, and were
verified by manual review of randomly selected cases.
Multiple logistic regression allowed us to characterize
the relative risk of a mutation, based on the adenoma
profile of mutation carriers vs. non-carriers and addi-
tional covariates.
Results
A total of 135 colonoscopy records were collected and
reviewed for 65 individuals who subsequently tested
negative for the family mutation, at a median age of 51
(standard deviation of 16 years) and average pathology-
confirmed adenoma count of 0.25 (mode = 0) at first
colonoscopy. For patients between 30 and 79 years of
age, 5% had 2 or more adenomas; 17% had a single ade-
noma, and 79% had no adenomas. Additional compar-
able data were available on 130 individuals from
negative branches of the kindred, who underwent colo-
noscopy between 1995 and 2009.
Conclusions
The combination of a long-running study with archived
records and a large, electronically searchable medical
database with a linked genealogical resource offers a
powerful platform for the development of hypothesis-
driven research. This resource may be used to address
both clinical and research questions whose answers may
be used to guide clinical management.
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